Trials / Completed
CompletedNCT05734716
Colorado-Oregon Altitude Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 121 (actual)
- Sponsor
- University of Oregon · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Investigating the utility of prophylactic treatment with iron sucrose and/or erythropoietin on the prevention of acute mountain sickness in fit, young, healthy individuals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Erythropoietin | use of erythropoietin to stimulate red blood cell development prior to ascent to altitude |
| DRUG | Iron sucrose (Venofer) | use of iron sucrose to stimulate red blood cell development prior to ascent to altitude |
| DRUG | Sterile Sodium Chloride | sham treatment with sterile saline |
Timeline
- Start date
- 2021-02-17
- Primary completion
- 2022-08-01
- Completion
- 2023-01-01
- First posted
- 2023-02-21
- Last updated
- 2023-03-10
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05734716. Inclusion in this directory is not an endorsement.